MX2012004033A - Procedimiento para fabricar acido 2-[(3,5-difluoro-3'-metoxi-1,1'- bifenil-4-il)amino]nicotinico. - Google Patents

Procedimiento para fabricar acido 2-[(3,5-difluoro-3'-metoxi-1,1'- bifenil-4-il)amino]nicotinico.

Info

Publication number
MX2012004033A
MX2012004033A MX2012004033A MX2012004033A MX2012004033A MX 2012004033 A MX2012004033 A MX 2012004033A MX 2012004033 A MX2012004033 A MX 2012004033A MX 2012004033 A MX2012004033 A MX 2012004033A MX 2012004033 A MX2012004033 A MX 2012004033A
Authority
MX
Mexico
Prior art keywords
difluoro
methoxy
amino
nicotinic acid
manufacturing
Prior art date
Application number
MX2012004033A
Other languages
English (en)
Inventor
Maria Carmen Boix Bernardini
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of MX2012004033A publication Critical patent/MX2012004033A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invención se refiere a un procedimiento para fabricar ácido 2- [(3,5-difluoro-3' -metoxi-1,1' -bifenil-4-il)amino]nicotínico, que comprende las etapas de: a) proporcionar 3,5-difluoro-3´ -metoxibifenil-4-amina, b) proporcionar y aislar una sal de aminio de la 3,5- difluoro-3´ -metoxibifenil-4-amina, y c) además hacer reaccionar la sal de aminio de 3,5- difluoro-3'-metoxibifeni l-4-amina obtenida en b) para obtener ácido 2-[(3,5-difluoro-3'-me toxi-1,1'-bifenil-4-il) amino] nicotínico.
MX2012004033A 2009-10-16 2010-10-14 Procedimiento para fabricar acido 2-[(3,5-difluoro-3'-metoxi-1,1'- bifenil-4-il)amino]nicotinico. MX2012004033A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09382212A EP2314577A1 (en) 2009-10-16 2009-10-16 Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid
PCT/EP2010/006283 WO2011045059A1 (en) 2009-10-16 2010-10-14 Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid

Publications (1)

Publication Number Publication Date
MX2012004033A true MX2012004033A (es) 2012-05-08

Family

ID=41402565

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004033A MX2012004033A (es) 2009-10-16 2010-10-14 Procedimiento para fabricar acido 2-[(3,5-difluoro-3'-metoxi-1,1'- bifenil-4-il)amino]nicotinico.

Country Status (32)

Country Link
US (1) US8598363B2 (es)
EP (2) EP2314577A1 (es)
JP (1) JP5809630B2 (es)
KR (1) KR101699999B1 (es)
CN (2) CN103936668A (es)
AU (1) AU2010306098B2 (es)
BR (1) BR112012008464B1 (es)
CA (1) CA2776328C (es)
CL (1) CL2012000739A1 (es)
CO (1) CO6430508A2 (es)
CR (1) CR20120185A (es)
CY (1) CY1115161T1 (es)
DK (1) DK2488497T3 (es)
EA (1) EA022805B1 (es)
ES (1) ES2467165T3 (es)
HK (1) HK1168101A1 (es)
HR (1) HRP20140523T1 (es)
IL (1) IL218446A (es)
IN (1) IN2012DN01938A (es)
ME (1) ME01812B (es)
MX (1) MX2012004033A (es)
MY (1) MY160308A (es)
NZ (1) NZ598429A (es)
PE (1) PE20121173A1 (es)
PL (1) PL2488497T3 (es)
PT (1) PT2488497E (es)
RS (1) RS53319B (es)
SI (1) SI2488497T1 (es)
SM (1) SMT201400064B (es)
UA (1) UA107811C2 (es)
WO (1) WO2011045059A1 (es)
ZA (1) ZA201201563B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
UY31272A1 (es) * 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
JP7343373B2 (ja) * 2019-12-02 2023-09-12 花王株式会社 香料組成物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL182198B1 (en) 1995-06-21 2001-11-30 Asta Medica Ag Pharmaceutic powder holding container with integrated measuring device and powdered
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
DE19610955A1 (de) 1996-03-20 1997-09-25 Hoechst Ag Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
GB9804343D0 (en) 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
JP2003504310A (ja) 1999-06-10 2003-02-04 ワーナー−ランバート・カンパニー アミロイドタンパク質凝集阻害方法およびアミロイド沈着物の画像化方法
DE60226855D1 (de) 2001-04-05 2008-07-10 Aventis Pharma Inc Verwendung von (z)-2-cyano-3-hydroxy-but-2-ensäure-(4'-trifluoromethylphenyl)-amid zur behandlung der multiplen sklerose
PE20030120A1 (es) 2001-06-19 2003-02-12 Merck & Co Inc Sal amina de un antagonista de receptor de integrin
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
WO2003006424A1 (en) 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US20050222124A1 (en) * 2002-02-13 2005-10-06 Bromidge Steven M Benzenesulfonamide derivatives as antipsychotic agents
EP1499592A4 (en) * 2002-04-13 2010-01-13 Hanlim Pharmaceutical Co Ltd AMLODIPINE NICOTINATE AND PROCESS FOR PREPARING THE SAME
PE20040844A1 (es) * 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
EP1581478A1 (en) 2002-12-23 2005-10-05 4Sc Ag Dhodh-inhibitors and method for their identification
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
SE0400234D0 (sv) 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
JP2008500393A (ja) 2004-05-21 2008-01-10 ザ ユーエービー リサーチ ファンデーション ピリミジン合成インヒビターに関する組成物および方法
WO2006022442A1 (ja) 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
AU2005295511A1 (en) 2004-10-19 2006-04-27 Aventis Pharmaceuticals Inc. Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
CN1696100B (zh) * 2005-06-01 2010-11-24 黑龙江福和华星制药集团股份有限公司 痤疮治疗药阿达帕林的新型简捷合成方法
ES2319596B1 (es) * 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
CA2677457A1 (en) 2007-02-06 2008-08-14 Helen Tuvesson Andersson New compounds, methods for their preparation and use thereof
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2210615A1 (en) 2009-01-21 2010-07-28 Almirall, S.A. Combinations comprising methotrexate and DHODH inhibitors
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
EP2230232A1 (en) 2009-03-13 2010-09-22 Almirall, S.A. Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
EP2228367A1 (en) 2009-03-13 2010-09-15 Almirall, S.A. Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors

Also Published As

Publication number Publication date
PL2488497T3 (pl) 2014-07-31
CR20120185A (es) 2012-06-11
EP2314577A1 (en) 2011-04-27
ZA201201563B (en) 2012-11-28
CA2776328A1 (en) 2011-04-21
IL218446A (en) 2014-08-31
US8598363B2 (en) 2013-12-03
NZ598429A (en) 2014-02-28
EA022805B1 (ru) 2016-03-31
DK2488497T3 (da) 2014-06-10
HK1168101A1 (en) 2012-12-21
EP2488497A1 (en) 2012-08-22
SMT201400064B (it) 2014-07-07
MY160308A (en) 2017-02-28
CY1115161T1 (el) 2016-12-14
HRP20140523T1 (hr) 2014-07-04
WO2011045059A1 (en) 2011-04-21
PT2488497E (pt) 2014-05-28
IL218446A0 (en) 2012-04-30
JP2013507407A (ja) 2013-03-04
BR112012008464B1 (pt) 2021-08-24
CN102574800A (zh) 2012-07-11
AU2010306098A1 (en) 2012-03-15
CN102574800B (zh) 2014-09-17
ES2467165T3 (es) 2014-06-12
CO6430508A2 (es) 2012-04-30
EA201200594A1 (ru) 2012-11-30
AU2010306098B2 (en) 2015-10-15
CA2776328C (en) 2017-08-08
SI2488497T1 (sl) 2014-08-29
BR112012008464A2 (pt) 2015-09-22
EP2488497B1 (en) 2014-03-12
IN2012DN01938A (es) 2015-08-21
KR101699999B1 (ko) 2017-01-26
UA107811C2 (en) 2015-02-25
JP5809630B2 (ja) 2015-11-11
KR20120087131A (ko) 2012-08-06
PE20121173A1 (es) 2012-08-30
US20120245359A1 (en) 2012-09-27
CN103936668A (zh) 2014-07-23
ME01812B (me) 2014-09-20
CL2012000739A1 (es) 2012-10-12
RS53319B (en) 2014-10-31

Similar Documents

Publication Publication Date Title
HRP20130456T1 (en) Novel process for the preparation of amino acid derivatives
ZA201200402B (en) Production of acid soluble soy protein isolates ("800")
MX344246B (es) Procedimiento para la preparacion de cloruros de acido 5-fluoro-1-alquil-3-fluoroalquil-1h-pirazol-4-carboxilico.
MX2012004033A (es) Procedimiento para fabricar acido 2-[(3,5-difluoro-3'-metoxi-1,1'- bifenil-4-il)amino]nicotinico.
WO2009080006A3 (de) Neuer mariendistelextrakt, verfahren zur herstellung und verwendung
PL2358662T3 (pl) Sposób amonolizy kwasu 11-bromoundekanowego
EP2448423A4 (en) PREPARATION OF ACID SOLUBLE SOY PROTEIN ISOLATES (S700)
UA106619C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
WO2011102640A3 (en) Method for preparing sitagliptin and amine salt intermediates used therein
AP2007004270A0 (en) Process for preparing salts of hydrocyanic acid
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
WO2009060297A3 (en) An improved process for the preparation of paliperidone and its intermediates
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
SI2016073T1 (sl) Postopek za pripravo ÄŤistega irbesartana
WO2012081036A3 (en) A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione)
MD4477C1 (ro) Procedeu de sinteză a 3-(2-bromo-4,5-dimetoxifenil)propannitrilului şi aplicarea acestuia în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid farmaceutic acceptabil
PL389029A1 (pl) Sposób wytwarzania kwasu 2,4-dichlorofenoksyoctowego
PL386128A1 (pl) Nowe kwasy bifenylo-4,4'diaminobis(metylobisfosfonowe) i związki pokrewne oraz sposób ich wytwarzania
UA34565U (ru) Способ получения органически-мономинерального цинксодержащего препарата "оргмет-3"
PL384486A1 (pl) Sposób wytwarzania kwasu 4,4-diaminodifenylomoczniko-3,3- disulfonowego
UA42783U (ru) Способ лечения дисбактериоза

Legal Events

Date Code Title Description
FG Grant or registration